Marleen E. Jansen

484 total citations
21 papers, 309 citations indexed

About

Marleen E. Jansen is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Marleen E. Jansen has authored 21 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Genetics. Recurrent topics in Marleen E. Jansen's work include Genomics and Rare Diseases (5 papers), Prenatal Screening and Diagnostics (5 papers) and Ethics in Clinical Research (5 papers). Marleen E. Jansen is often cited by papers focused on Genomics and Rare Diseases (5 papers), Prenatal Screening and Diagnostics (5 papers) and Ethics in Clinical Research (5 papers). Marleen E. Jansen collaborates with scholars based in Netherlands, Australia and Germany. Marleen E. Jansen's co-authors include Martina C. Cornel, Tessel Rigter, Lidewij Henneman, Wendy Rodenburg, Angela Brand, Ralf Sudbrak, Jonathan A. Lal, Wolfgang Ballensiefen, Lada Leyens and Denis Horgan and has published in prestigious journals such as Journal of Medical Internet Research, Frontiers in Pharmacology and European Journal of Human Genetics.

In The Last Decade

Marleen E. Jansen

21 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marleen E. Jansen Netherlands	10	111	82	67	67	52	21	309
Lena Dolman Canada	7	192 1.7×	26 0.3×	5 0.1×	106 1.6×	12 0.2×	8	471
Ebony Madden United States	10	107 1.0×	40 0.5×	3 0.0×	117 1.7×	44 0.8×	18	305
Michael Muenzberg United States	10	116 1.0×	144 1.8×	18 0.3×	30 0.4×	6 0.1×	16	516
Jonathan S. Chang United States	14	14 0.1×	20 0.2×	7 0.1×	39 0.6×	76 1.5×	50	569
Joan Henthorn United Kingdom	14	37 0.3×	219 2.7×	25 0.4×	17 0.3×	6 0.1×	31	509
Kristan Augustin United States	10	25 0.2×	38 0.5×	7 0.1×	56 0.8×	10 0.2×	20	310
Ewa Stawowczyk Poland	10	87 0.8×	44 0.5×	4 0.1×	11 0.2×	11 0.2×	23	322
Tariq S. Marroush United States	9	141 1.3×	6 0.1×	9 0.1×	55 0.8×	5 0.1×	14	346
Iván de Jesús Ascencio-Montiel Mexico	8	50 0.5×	10 0.1×	7 0.1×	22 0.3×	9 0.2×	27	257
Jilles M. Fermont United Kingdom	8	64 0.6×	14 0.2×	8 0.1×	33 0.5×	3 0.1×	11	400

Countries citing papers authored by Marleen E. Jansen

Since Specialization

Citations

This map shows the geographic impact of Marleen E. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen E. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen E. Jansen more than expected).

Fields of papers citing papers by Marleen E. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marleen E. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen E. Jansen. The network helps show where Marleen E. Jansen may publish in the future.

Co-authorship network of co-authors of Marleen E. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Marleen E. Jansen. A scholar is included among the top collaborators of Marleen E. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen E. Jansen. Marleen E. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jansen, Marleen E., et al.. (2024). Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development Study. Journal of Medical Internet Research. 26. e47389–e47389. 2 indexed citations

Jansen, Marleen E., et al.. (2023). Comment on Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20. International Journal of Neonatal Screening. 9(1). 7–7. 2 indexed citations

Jansen, Marleen E., Tessel Rigter, Patrick C. Souverein, et al.. (2023). Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users. Genes. 14(2). 456–456. 2 indexed citations

Jansen, Marleen E., et al.. (2022). Pursuing Public Health Benefit Within National Genomic Initiatives: Learning From Different Policies. Frontiers in Genetics. 13. 865799–865799. 6 indexed citations

Dijk, Tessa van, et al.. (2021). Informing Parents about Newborn Screening: A European Comparison Study. International Journal of Neonatal Screening. 7(1). 13–13. 15 indexed citations

Jansen, Marleen E., et al.. (2021). Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders. Frontiers in Pediatrics. 9. 635353–635353. 9 indexed citations

Dijk, Tessa van, Marleen E. Jansen, Wybo Dondorp, et al.. (2021). Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective. Frontiers in Pediatrics. 9. 706394–706394. 15 indexed citations

Jansen, Marleen E., et al.. (2021). Kansen en risico's van DNA-zelftesten. Rivm (National Institute for Public Health and the Environment). 1 indexed citations

Cornel, Martina C., Tessel Rigter, Marleen E. Jansen, & Lidewij Henneman. (2020). Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide. Journal of Community Genetics. 12(2). 257–265. 39 indexed citations

10.

Blom, Maartje, Robbert G. M. Bredius, Marleen E. Jansen, et al.. (2020). Parents’ Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands. Journal of Clinical Immunology. 41(1). 99–108. 29 indexed citations

11.

Rigter, Tessel, et al.. (2020). Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective. Frontiers in Genetics. 11. 10–10. 41 indexed citations

12.

Jansen, Marleen E., et al.. (2019). C-reactive protein as a marker of persistent Chlamydia trachomatis infection is not associated with tubal factor infertility—an independent clinical validation study. Human Reproduction Open. 2019(4). hoz029–hoz029. 4 indexed citations

13.

Jansen, Marleen E., et al.. (2019). Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study. BMC Pediatrics. 19(1). 230–230. 5 indexed citations

14.

Jansen, Marleen E., et al.. (2017). The attitudes of Dutch fertility specialists towards the addition of genetic testing in screening of tubal factor infertility. Sexual & Reproductive Healthcare. 12. 123–127. 3 indexed citations

15.

Jansen, Marleen E., Tessel Rigter, Wendy Rodenburg, et al.. (2017). Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity. Frontiers in Pharmacology. 8. 555–555. 16 indexed citations

16.

Jansen, Marleen E., et al.. (2017). Policy Making in Newborn Screening Needs a Structured and Transparent Approach. Frontiers in Public Health. 5. 53–53. 14 indexed citations

17.

Jansen, Marleen E., et al.. (2016). International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents. European Journal of Human Genetics. 25(1). 10–16. 29 indexed citations

18.

Jansen, Marleen E., et al.. (2015). Characteristics of child health care practitioners in overweight prevention of children. Applied Nursing Research. 29. 157–162. 1 indexed citations

19.

Jansen, Marleen E., et al.. (2015). Potential protective effect of a G>A SNP in the 3′UTR ofHLA-AforChlamydia trachomatissymptomatology and severity of infection. Pathogens and Disease. 74(2). ftv116–ftv116. 5 indexed citations

20.

Horgan, Denis, Marleen E. Jansen, Lada Leyens, et al.. (2014). An Index of Barriers for the Implementation of Personalised Medicine and Pharmacogenomics in Europe. Public Health Genomics. 17(5-6). 287–298. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact